NCT05341258View on ClinicalTrials.gov

Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Critical IllnessVentilation Perfusion MismatchShockPulmonary EmbolismTraumaCopd
Interventions
DIAGNOSTIC_TEST

EtCO2

EtCO2

DIAGNOSTIC_TEST

PaCO2

PaCO2

Trial Locations (1)

34255

Gaziosmanpasa Training Research Hospital, Istanbul

All Listed Sponsors
lead

Gaziosmanpasa Research and Education Hospital

OTHER_GOV

NCT05341258 - Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients | Biotech Hunter | Biotech Hunter